http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2414206-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a6907c0df7c11e72803b375909e45fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
filingDate | 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fba409fd58742cc3f13f55ce548eba1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3f0bff1c920c3eaf780643495ef04de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2395b85fd481b1e436fe87495a82cb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ffef836579578b50a5fb4d436cdaa63 |
publicationDate | 2011-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2414206-C1 |
titleOfInvention | Method of reducing spontaneous erythrocyte aggregation in case of arterial hypertension with abdominal obesity and dyslipidemia |
abstract | FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to hematology and cardiology. Method includes administration to patients of complex from hypocaloric diet, dosed static and dynamic physical activity, including morning hygienic gymnastics, preventive medical gymnastics, divided physical exercise throughout the day, daily swimming for not less than 30 min per day in the middle of the day, intake of lisinopril in dose 10 mg 1 time per day in the morning and simvastatin 20 mg 1 time per day in the morning during 2 months. Combined application of all components makes it possible to reduce SEA in patients with AH with AO and D, reducing it to the level close to such for healthy people, during 2 months of treatment. ^ EFFECT: reduction of spontaneous erythrocyte aggregation (SEA) in case of arterial hypertension (AH) with abdominal obesity (AO) and dyslipidemia (D). ^ 2 ex |
priorityDate | 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.